---
layout: cv
title: Samuel Whittle's CV
---
# Samuel Whittle
Rheumatologist & Epidemiologist

Rheumatology Unit, The Queen Elizabeth Hospital<br/>
28 Woodville Road, Woodville South<br/>
South Australia 5011<br/>

<a href="samuel.whittle@sa.gov.au">samuel.whittle@sa.gov.au</a> - +618 8222 6688  

<div id="webaddress">
  <a href="https://sam.xyz"><i class="fas fa-home"></i> sam.xyz</a> - 
  <a href="https://orcid.org/0000-0001-7417-7691"><i class="ai ai-orcid"></i> 0000-0001-7417-7691</a> - 
  <a href="https://twitter.com/samwhittle"><i class="fab fa-twitter"></i> @samwhittle</a>
</div>

## Qualifications

`1997`
**Bachelor of Medicine, Bachelor of Surgery (Honours)**, *University of Adelaide*  

`2004`
**Fellow of the Royal Australasian College of Physicians**   

`2010`  
**Master of Clinical Epidemiology (with Distinction)**, *University of Newcastle*

## Experience

`2005-present`
**Staff Specialist in Rheumatology**, *The Queen Elizabeth Hospital*, Adelaide, South Australia.

`2013-present`
**Senior Lecturer**, *The University of Adelaide*, South Australia.

`2018-present`
**ANZMUSC Practitioner Fellow** 

`2018-present`
**Adjunct Senior Research Fellow**, *Monash University*, Melbourne, Australia.

`2009-2011`
**Staff Specialist in Rheumatology**, *The Lyell McEwin Hospital*, Adelaide, South Australia.

`2006-2008`
**Director, Physician Training**, *The Queen Elizabeth Hospital*, Adelaide, South Australia.

`2005-2009`
**Rheumatology Private Practice**, *Wakefield House*, Adelaide, South Australia.

`2005`
**Research Student**, *The University of Adelaide*, South Australia.

`2004`
**Advanced Trainee in Rheumatology**, *Repatriation General Hospital & Flinders Medical Centre*, Adelaide, South Australia.

`2003`
**Specialist Registrar in Rheumatology**, *St Peter's Hospital*, Chertsey, Surrey, UK.  

`2002`
**Advanced Trainee in Rheumatology**, *The Royal Adelaide Hospital & The Queen Elizabeth Hospital*, Adelaide, South Australia.  

`1998-2001`
**Basic Physician Trainee**, *The Royal Adelaide Hospital*, Adelaide, South Australia.  

`1997`
**Intern**, *The Royal Adelaide Hospital*, Adelaide, South Australia.  


## Publications

*Publication list also available [in Google Scholar](https://scholar.google.com/citations?sortby=pubdate&hl=en&user=6P9otGEAAAAJ&view_op=list_works).*  


`2021` 
1. Sharma C, **Whittle S**, Haghighi P, Burstein F, Keen H. Response to 'Correspondence on 'Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis'' by Reuter et al. Ann Rheum Dis. 2021 Feb. doi.org/10.1136/annrheumdis-2020-219815  
2. Ferreira GE, Zadro JR, O’Keeffe M, Buchbinder R, Maher C, Latimer J, et al. Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Intern Med J. 2021;51: 622.  
3. Venter G, Tieu J, Black R, Lester S, Leonardo N, **Whittle SL**, et al. Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis. ACR Open Rheumatology. 2021; 3(4): 231-238. doi:10.1002/acr2.11234  
4. Adams L, Lester S, Hoon E, van der Haak H, Proudman C, Hall C, **Whittle S**, Proudman S, Hill C. Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia. Internal Medicine Journal 2021. In press.  

`2020`  
5. Davis CR, Ruediger CD, Dyer KA, Lester S, Graf SW, Kroon FPB, **Whittle SL**, Hill CL. Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis Cartilage. 2020. doi:10.1016/j.joca.2020.11.002  
6. Buchbinder R, Ramiro S, Huang H, Gagnier JJ, Jia Y, **Whittle SL**. Measures of adult shoulder function. Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:250-293. doi: 10.1002/acr.24230  
7. Sharma C, **Whittle S**, Haghighi PD,Burstein F, Keen H. Sentiment analysis of social media posts on pharmacotherapy: A scoping review. Pharmacol Res Perspect. 2020;e00640. https://doi.org/10.1002/prp2.640  
8. Sharma C, **Whittle SL**, Delir Haghighi P, Burstein F, Sa’adon R, Keen H. Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. Ann Rheum Dis 2020. https://doi:10.1136/annrheumdis-2020-217333.  
9. Lowe J, Briggs AM, **Whittle S**, Stephenson MD. A systematic review of the effects of probiotic administration in inflammatory arthritis. Complement Ther Clin Pract. 2020; 101207.  
10. Leonardo N, Lester S, Graham M, Barrett C, **Whittle S**, Rowett D, et al. Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. Int J Rheum Dis. 2020;15: 1586.  
11. Putman MS, Sufka P, **Whittle S**, Robinson PC. European consensus statements for interstitial lung disease in systemic sclerosis [letter]. The Lancet Rheumatology. 2020;2: e317–e318.  
12. Hazlewood GS, **Whittle SL**, Kamso MM, Akl EA, Wells GA, Tugwell P, et al. Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis. Cochrane Database Syst Rev. 2020 [cited 8 Apr 2020]. doi:10.1002/14651858.CD013562  
13. Khadra Y, Walker JG, Hakendorf P, Proudman S, Rischmueller M, Hill CL, **Whittle S**, et al. Scleroderma Renal Crisis: Observations from the South Australian Scleroderma Register. Intern Med J. 2020. doi:10.1111/imj.14772  
14. Røe Y, Buchbinder R, Grotle M, **Whittle S**, Ramiro S, Huang H, et al. What do the OMERACT Shoulder Core Set candidate instruments measure? An analysis using the refined ICF linking rules. J Rheumatol. 2020. doi:10.3899/jrheum.190832   
15. Leonardo N, Lester S, **Whittle S**, Rischmueller M. Review of gout clinic in a tertiary hospital setting. Intern Med J. 2020;50: 117–120.  
16. Szeto C-C, Sugano K, Wang J-G, Fujimoto K, **Whittle S**, Modi GK, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020; gutjnl–2019–319300.  
17. Cai  K, **Whittle  SL**, Richards  BL, Ramiro  S, Falzon  L, Buchbinder  R. Marine oil supplements for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2019, Issue 12. Art. No.: CD010250. DOI: 10.1002/14651858.CD010250.pub2.  

`2019`  
18. Ng J, Little CB, Woods S, **Whittle S**, Lee FY, Gronthos S, et al. Stem Cell Directed Therapies for Osteoarthritis: the promise and the practice: Concise Review. Stem Cells. 2019. doi:10.1002/stem.3139  
19. **Whittle SL**, Johnston RV, McDonald S, Paterson KL, Buchbinder R. Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee. [protocol]. Cochrane Database Syst Rev. 2019;24: 166.  
20. **Whittle SL**, Johnston RV, McDonald S, Worthley D, Mark Campbell T, Buchbinder R. Stem cell injections for osteoarthritis of the knee. [protocol]. Cochrane Database Syst Rev. John Wiley & Sons, Ltd; 2019; doi:10.1002/14651858.CD013342  
21. Chan FLY, Lester S, **Whittle SL**, Hill CL. The utility of ESR, CRP and platelets in the diagnosis of GCA. BMC Rheumatology. 2019;3: 14.  
22. Page MJ, O’Connor DA, Malek M, Haas R, Beaton D, Huang H, Ramiro S, Richards P, Voshaar  MJ, Shea B, Verhagen AP, **Whittle SL**, van der Windt DA, Gagnier JJ, Buchbinder R. Patients’ experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology. 2019; doi:10.1093/rheumatology/kez046  
23. Tam LS, Wei JC-C, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawakit P, Dans L, Gu J, Hagino N, Kishimoto M, Reyes HM, Soroosh S, Stebbings S, **Whittle SL**, Yeap SS, Lau CS. 2018 APLAR axial spondyloarthritis treatment recommendations. Int J Rheum Dis. 2019; doi:10.1111/1756-185X.13510  
24. Ramiro S, Page MJ, **Whittle SL**, Huang H, Verhagen AP, Beaton D, et al. The Omeract Core Domain Set for Clinical Trials of Shoulder Disorders. J Rheumatol. 2019; doi:10.3899/jrheum.181070  
25. Wilsdon TD, **Whittle SL**, Thynne TR, Mangoni AA. Methotrexate for psoriatic arthritis. Cochrane Database Syst Rev. 2019;1: CD012722.  

`2018`  
26. Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G, Harris IA, Hill C, Hiller C, Kamper SJ, Latimer J, Lawson A, Lin C-WC, Maher C, Perriman D, Richards BL, Smitham P, Taylor WJ, **Whittle S**, Buchbinder R. Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open. 2018;8: e023962.   
27. Buchbinder R, Bourne A, Latimer J, Harris I, **Whittle S**, Richards B, et al. Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Intern Med J. 2018; doi:10.1111/imj.14191  
28. Chua AC, Venkataraman K, **Whittle SL**. Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy. Internal Medicine Journal 2018; 48(9): 1163-4. http://dx.doi.org/10.1111/imj.14022  
29. Lowe J, Briggs A, **Whittle S**, Hoon E, Stephenson M. Effectiveness of probiotics in the management of inflammatory arthritis: a systematic review protocol. JBI Database System Rev Implement Rep. 2018; doi:10.11124/JBISRIR-2017-003692  
30. Pisaniello HL, Lester S, Gonzalez-Chica D, Stocks N, Longo M, Sharplin G, Dal Grande E, Gill T, **Whittle SL**, Hill C. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study. Arthritis Res Ther (2018). Arthritis Res Ther. 2018 Jul 11;20(1):143. doi: 10.1186/s13075-018-1633-9.  

`2017`  
31. Black RJ, Lester S, Buchbinder R, Barrett C, Lassere M, March L, **Whittle S**, Hill CL. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Res Ther (2017); 19:253. DOI 10.1186/s13075-017-1461-3  
32. Wilsdon TD, **Whittle SL**, Thynne TRJ, Mangoni AA. Methotrexate for psoriatic arthritis (Protocol). Cochrane Database of Systematic Reviews 2017, Issue 7. Art. No.: CD012722. DOI: 10.1002/14651858.CD012722.  
33. Goldacre, B., **Whittle, S**, Ernst, E. & Mendel, J. Authors’ reply to Beales. BMJ 356, j1196 (2017).  
34. Delir Haghighi P, Kang Y-B, Buchbinder R, Burstein F, **Whittle S**. Investigating Subjective Experience and the Influence of Weather Among Individuals With Fibromyalgia: A Content Analysis of Twitter. JMIR Public Health and Surveillance 3, e4 (2017).  

`2016`  
35. Truong SL, Saad NF, Robinson PC, Cowderoy G, Lim I, Schachna L, Stebbings S, Stuckey S, Taylor AL, **Whittle SL**, Zochling J, Bird P, Brown MA. Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. J Med Imaging Radiat Oncol. 2016 Dec 19. doi:10.1111/1754-9485.12573.    
36. Mendel J, Goldacre B, Ernst E, **Whittle S**. Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis. BMJ. 2016 Sep 9;i4626.  
37. Pisaniello HL & **Whittle SL**. Fibromyalgia:  Finding the Silver Lining around a Common Chronic Pain Disorder. Medicine Today 2016; 17(12): 54-56  
38. Milman N, Hill CL, **Whittle SL**, El Sayad J, Wells GA. Methotrexate for giant cell arteritis (protocol). In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2016 May 26]. Available from: http://onlinelibrary.wiley.com.proxy.library.adelaide.edu.au/doi/10.1002/14651858.CD005323.pub3/abstract   
39. Milman N, **Whittle SL**, Hill CL, El Sayad J, Wells GA. Methotrexate for polymyalgia rheumatica (protocol). In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2016 May 26]. Available from: http://onlinelibrary.wiley.com.proxy.library.adelaide.edu.au/doi/10.1002/14651858.CD005325.pub3/abstract   

`2015`  
40. Ting KH, Hill CL, **Whittle SL**. Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines. Int J Rheum Dis. 2015 Jun;18(5):488-94. doi: 10.1111/1756-185X.12699.  
41. Graf SW, **Whittle SL**, Wechalekar MD, Moi JHY, Barrett C, Hill CL, Littlejohn G, Lynch N, Major G, Taylor AL, Buchbinder R, Zochling J. Australian and New Zealand Recommendations for the Diagnosis and Management of Gout: integrating systematic literature review and expert opinion in the 3e initiative. Int J Rheum Dis. 2015 Mar;18(3):341-51. doi: 10.1111/1756-185X.12557. Epub 2015 Apr 17.  
42. Ting K, Graf SW & **Whittle SL**. Update on the diagnosis and management of gout. Med J Aust 2015; 203 (2): 86-88.  
43. **Whittle S** & Buchbinder R. In The Clinic: Rotator Cuff Disease. Ann Intern Med. 2015 Jan 6;162(1):ITC1.    

`2014`
44. Graf SW & **Whittle SL**. Isotretinoin-induced skeletal hyperostosis. Springerplus 2014 Nov 27;3(1):698.  
45. Moghaddami M, James M, **Whittle SL**, Cleland LG. Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro. Clin Trans Immunol. 2014 Aug 8;3(8):e23.   
46. Richards BL, **Whittle SL**, Buchbinder R, Barrett C, Lynch N, Major G, et al. Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis. International Journal of Rheumatic Diseases [Internet]. 2014 [cited 2014 Jun 3]; Available from: http://onlinelibrary.wiley.com/doi/10.1111/1756-185X.12388/full  
47. Robinson PC, Bird P, Lim I, Saad N, Schachna L, Taylor AL, **Whittle SL**, Brown MA. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases. 2014 (epub ahead of print; DOI 10.1111/1756-185X.12358)  
48. Bourne, A. M., **Whittle, SL**, Richards, B. L., Maher, C. G. & Buchbinder, R. The scope, funding and publication of musculoskeletal clinical trials performed in Australia. Med. J. Aust. 200(2): 88-91, (2014).  

`2013`  
49. **Whittle SL**, Colebatch AN, Adams K, Englbrecht M, Hazlewood G, et al. Multinational Evidence-Based Recommendations for Pain Management by Pharmacotherapy in Inflammatory Arthritis: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3e Initiative. Rheumatology (March 24, 2012). Available from: http://rheumatology.oxfordjournals.org/content/early/2012/03/23/rheumatology.kes032.  
50. **Whittle SL**, Buchbinder R. Opioid analgesics for rheumatoid arthritis pain. JAMA 309, 485–486 (2013).  
51. Graf, SW, Buchbinder, R, Zochling, J & **Whittle, SL**. The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: A systematic review. Clin Rheumatol. 2013 Feb;32(2):225-32.  

`2012`  
52. **Whittle SL**, Richards, B. L., Ramiro, S. & Buchbinder, R. Fish oil supplements for rheumatoid arthritis [protocol]. In: Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 2012). at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010250/abstract   
53. **Whittle SL**, Richards, BL, van der Heijde, DM. & Buchbinder, R. The efficacy and safety of opioids in inflammatory arthritis: a cochrane systematic review. J Rheumatol Suppl 90, 40–46 (2012).  
54. Richards, BL, **Whittle SL**, van der Heijde, DM & Buchbinder, R. Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 90, 28–33 (2012).  
55. Richards, BL, **Whittle SL**, van der Heijde, DM & Buchbinder, R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 90, 21–27 (2012).  
56. Richards, BL,** Whittle SL**, van der Heijde, DM & Buchbinder, R. The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 90, 34–39 (2012).  
57. Richards BL, **Whittle SL**, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1:CD008921.   
58. Richards BL, **Whittle SL**, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1:CD008922.   
59. Wechalekar MD, Lester S, Proudman SM, Cleland LG, **Whittle SL**, Rischmueller M, et al. Active foot synovitis: Criteria for remission and disease activity underestimate foot involvement in rheumatoid arthritis. Arthritis & Rheumatism 2012; 64(5): 1316-1322  

`2011`  
60. **Whittle SL**, Richards BL, Husni E, Buchbinder R. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev. 2011;11:CD003113.   
61. Richards BL, **Whittle SL**, Buchbinder R. Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2011;11:CD008920.   

`2010`  
62. Wechalekar MD, Rischmueller M, **Whittle S**, Burnet S, Hill CL. Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. J Clin Rheumatol. 2010 Mar;16(2):79–80.   
63. Katikireddi VS, **Whittle SL**, Hill CL. Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. Int J Rheum Dis. 2010 Feb 1;13(1):12–26.   

`2009`  
64. **Whittle SL**, Cole A, Lester S, Hill CL. Steroid sparing drug treatments for polymyalgia rheumatica [Protocol]. In: The Cochrane Collaboration, Hill CL, editors. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2009 [cited 2011 Apr 13]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005325/abstract.html  
65. Hill CL, Cole A, Lester S, **Whittle SL**. Steroid sparing drug treatments for giant cell arteritis [Protocol]. In: The Cochrane Collaboration, Hill CL, editors. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2009 [cited 2011 Apr 13]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD005323/abstract.html  

`2008`  
66. Mangat P, **Whittle S**, Cleland L, Limaye V. Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy. Clin. Rheumatol. 2008 Dec;27(12):1593–5.   

`2004`   
67. **Whittle SL**, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford). 2004 Mar;43(3):267–71.  
68. **Whittle SL**, Hughes RA. Methotrexate and folic acid: what is the optimal combination? (Letter). Rheumatology (Oxford). 2004 Aug; 43(8): 1061  

`2002`  
69. **Whittle SL**, James M, Cleland LG. Focus on Meloxicam (Review). Medicine Today 2002; 3(9): 73-76  

`1996`  
70. Edwards DJ, **Whittle S**L, Nissen MJ, Cohen B, Oakeshott RD, Keene GC. Radiographic changes in the knee after meniscal transplantation. An experimental study in a sheep model. Am J Sports Med. 1996 Apr;24(2):222–6.

## Grants and funding

`2018-2021`
**ANZMUSC Practitioner Fellowship** ($398,520) 

`2018` 
**Arthritis Australia Project Grant**  (CIB): *Community perceptions of rheumatoid arthritis pharmacotherapy: an analysis of social media platforms* ($35,000)  

`2020-2021`
**Therapeutic Guidelines Ltd (TGL)/RACGP Foundation Research Grant** (TGL-03) (CI): *Use of Osteoarthritis Guidelines in General Practice: An Analysis of Work-as-Done Using the Functional Resonance Analysis Method*. ($19,968)   

`2019-2022`
**Australian Commonwealth Government Value in Prescribing Program: Biological Disease-Modifying Anti-Rheumatic Drugs** (GO1512) (Consortium Member) ($8,411,402)   

`2021-2024`
**MRFF Efficient Use of Existing Medicines** (APP2007502) (CII): *Cost-utility comparison of down-titration strategies for safer and more efficient use of biologics in adults with rheumatoid arthritis and psoriatic arthritis*, ($2.7M)


## Awards and honors

`2017`
**Best Clinical Science Free Paper**, Australian Rheumatology Association Annual Scientific Meeting, Auckland, May 2017 (_The DAS28-P Index as a predictor of poor subjective response to DMARD therapy in early rheumatoid arthritis_) 

`2017`
**Tom Highton Award for Best Presentation** at the Annual Scientific Meeting of the New Zealand Rheumatology Association, Auckland, May 2017 (_The DAS28-P Index as a predictor of poor subjective response to DMARD therapy in early rheumatoid arthritis_)  

`2018`
**Best Poster**, OMERACT 2018, Terrigal NSW, May 2018 (*Instruments Measuring Pain in Shoulder Disorders*)  


## Invited talks

`2021`
Invited international speaker, New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin NZ, August 2021  

_An Australian living guideline for the pharmacological management of inflammatory arthritis_, Cabrini Research Sessions, 12th May 2021  

_An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis: Recommendations on Opioids for Pain in Inflammatory Arthritis_, Australian Rheumatology Association Webinar Series, 16th February 2021  

`2020`

_Development of the ANZMUSC Living Guidelines Conflict of Interest Process_, ANZMUSC Clinical Trials Network Mid-Year Scientific Meeting, 6 October 2020  

_An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis: bDMARD Tapering Recommendations_, Australian Rheumatology Association Webinar Series, 16th November 2020  

_On Building a Living Evidence Ecosystem in Musculoskeletal Disease_, Australasian Society of Clinical Immunology and Allergy Educational Meeting, Adelaide, 15 December 2020  

`2019`  

_Talking Fibromyalgia_, Arthritis SA Community Seminar, 17 February 2019   

_Living Network Meta-analysis_, Cochrane Webinar, 21 March 2019  

_Biologics in Rheumatic Diseases 2019: Spoiled for Choice_, ASCEND Nurse Education Meeting, Adelaide, August 2019  

_On Building A Living Evidence Ecosystem in Musculoskeletal Disease_, RACP SA Annual Scientific Meeting, Adelaide, November 2019   

`2018`  

_ANZMUSC & Living Evidence: An Introduction_, ANZMUSC Update Meeting, Sydney, 28 November 2018  

`2017`  

_Fibromyalgia: A Rheumatological Construct?_, Arthritis SA Health Professionals Conference, 23 June 2017  

_Fibromyalgia_, Arthritis SA Community Seminar, 22 Oct 2017   

`2016`  

_Joint Pain in Osteoarthritis_, Global Year Against Pain in the Joints Public Forum, Australian Rheumatology Association Annual Scientific Meeting, Darwin, May 2016   

_Predictors of Response to Therapy in Psoriasis and Psoriatic Arthritis_, Novartis Rheumatology and Dermatology Preceptorship. Sydney, 17th September 2016  

_Ankylosing Spondylitis: TNF Inhibition and Beyond_, Novartis Rheumatology and Dermatology Preceptorship. Sydney, 18th September 2016  

_Chronic pain in rheumatology: fibromyalgia and beyond_, Faculty of Pain Medicine Regional CME meeting, Adelaide, 7th November 2016  


## Research Supervision  

- Chinu  
- Jess  
- etc

*add professional service*


## University service
`2021-present`
**Vice director**, *Masters program in Geology and Geophysics*, University of Helsinki, Helsinki, Finland.

`2020-present`
**Deputy director**, *Institute of Seismology, University of Helsinki*, Helsinki, Finland.

`2018-present`
**Steering group member**, *Bachelor’s Programme in Science (in English)*, University of Helsinki, Helsinki, Finland.

**Deputy member**, *Department of Geosciences and Geography mangagement group, University of Helsinki*, Helsinki, Finland.

**Leader**, *Department of Geosciences and Geography well-being group, University of Helsinki*, Helsinki, Finland.

**Member**, *Department of Geosciences and Geography communications group, University of Helsinki*, Helsinki, Finland.

`2013-present`
**Co-coordinator geoscience seminar**, *Department of Geosciences and Geography, University of Helsinki*, Helsinki, Finland.

`2017-2020`
**Steering group member**, *Masters program in Geology and Geophysics*, University of Helsinki, Helsinki, Finland.

`2017-2018`
**Preparatory group member**, *BSc of Science in English degree, University of Helsinki*, Helsinki, Finland.

`2015-2017`
**Department council member**, *Department of Geosciences and Geography, University of Helsinki*, Helsinki, Finland.

`2014-2016`
**Co-coordinator of Solid Earth Geophysics Masters program**, *Department of Geosciences and Geography, University of Helsinki*, Helsinki, Finland.

`2007-2008`
**Graduate Student Mentor**, *Department of Geological Sciences, University of Michigan*, Ann Arbor, Michigan, USA.

## Community outreach
`2020`
**Guest lecture**, *Kumpula Campus, University of Helsinki*, Finland.<br/>
Introduction to the geodynamics of the Himalayan orogen for visiting high school students from the Germal School Helsinki

`2015`
**Guest lecture**, *Institute of Seismology, University of Helsinki*, Helsinki, Finland.<br/>
Introduction to my general areas of research on mountain evolution for visiting high school students from Tampere, Finland

`2013`
**Presenter**, *Science Bazaar, University of Helsinki*, Helsinki, Finland.<br/>
Presentation on mountain systems to the audience of undergraduate students present for their orientation at the Kumpula Science Campus of the University of Helsinki

`2007`
**Guest lecture**, *Melbourne High School*, Melbourne, FL, USA.<br/>
Introduction to the geology and culture of Nepal related to reading of Jon Krakauer’s *Into Thin Air* for eleventh grade English students

## Memberships

`2014-present`
European Geosciences Union

`2005-present`
Geological Society of America

`2003-present`
American Geophysical Union

## Languages

Native: English

Basic: Finnish, French, German

## Personal

Birth date: 9 March 1980

Citizenship: USA

Residence: Finland (Permanent resident)

Family: Married, two children

<br/>Last updated: February 2021<br/><br/>
